2cureX AB
Research 2cureX AB (2CUREX) on Bullrun: market cap SEK 46.39M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2CUREX
- ExchangeST
- CountryDenmark
- SectorHealthcare
- IndustryBiotechnology
- CurrencySEK
- Market capSEK 46.39M
- Financial periodFY2024
- Net income-SEK 4.55M
- Free cash flow-SEK 4.63M
Valuation Snapshot
latest market cap is SEK 46.39M.
About 2cureX AB
2cureX AB (publ) operates as a medical technology company in Europe. ts proprietary IndiTreat test family creates various three-dimensional tumoroids derived from fresh samples of colorectal cancer (CRC) tissue that has been obtained from an individual patient's metastatic colorectal cancer. 2cureX AB (publ) was incorporated in 2006 and is based in Landskrona, Sweden.
Frequently asked questions
What is 2cureX AB's market cap?
2cureX AB's market capitalization is SEK 46.39M.
What does 2cureX AB do?
2cureX AB (publ) operates as a medical technology company in Europe. ts proprietary IndiTreat test family creates various three-dimensional tumoroids derived from fresh samples of colorectal cancer (CRC) tissue that has been obtained from an individual patient's metastatic colorectal cancer.